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Abstract: The alpha 2-adrenoceptor antagonists atipamezole and yohimbine were used to antagonize medetomidine-induced
sedation in 6-8-month-old native breed female goats. Intramuscular injection of medetomidine at the dose rate of 40 μg/kg body
weight induced sedation and recumbency within 10-20 min in the goats. After recumbency, the goats were injected with saline (5
ml) (control group), atipamezole (0.2 mg/kg), or yohimbine (0.2 mg/kg) via the jugular vein. The duration of recumbency in the
control group was 90 ± 9 min (mean ± SE). The effects of sedation continued in the control group goats even after regaining the
righting reflex and standing. Atipamezole and yohimbine significantly reduced the recumbency period to 2 ± 1 and 45 ± 8 min,
respectively, in comparison to the control group. The signs of arousal consisted of head raising, assuming sternal recumbency, and
standing within 1 min in the atipamezole group and within 15-20 min in the yohimbine group. In contrast to the control group, the
atipamezole- and yohimbine-treated goats appeared alert after standing. Atipamezole significantly, but partially reversed
medetomidine-induced reductions in heart rate and ruminal contractions, whereas yohimbine partially reversed the medetomidineinduced decrease in heart rate only. The data suggest that atipamezole is useful for antagonizing the central nervous system
depressant effects of medetomidine in goats. Atipamezole was also superior to yohimbine as a medetomidine antagonist.
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Introduction
The alpha 2-adrenoceptor agonist medetomidine is
most commonly used in wild animals, dogs, and cats as an
analgesic, sedative, and muscle relaxant (1-3). The drug
also has clinical use in domestic small ruminants, such as
sheep and goats (4-12). Medetomidine acts on
presynaptic alpha 2-adrenoceptors in the central nervous
system, decreasing catecholamine release and turnover,
and subsequently inducing sedation in animals (1,12). Due
to the profound central nervous system depressant
effects of medetomidine in animals, several reports
indicate the usefulness of atipamezole or yohimbine as
specific alpha 2-adrenoceptor antagonists of the drug in
goats (6,7) and sheep (11,12). Medetomidine variably
causes bradycardia, ruminal atony, and bloating, with or
without hypoxemia in goats (4,7,13) and sheep (5,8,11).

In sheep atipamezole and yohimbine are equally
effective in reversing medetomidine-induced loss of the
righting reflex (11). In goats yohimbine has not been used
to reverse the effects of medetomidine. The purpose of
the present study was to examine the antagonistic effects
of atipamezole and yohimbine on medetomidine-induced
loss of the righting reflex in sedated goats, taking into
consideration changes in the heart rate and ruminal
motility of the animals.

Materials and Methods
The study included 12 apparently healthy 6-8-monthold female native breed goats. The goats were fed a
concentrate diet with water and straw ad libitum. The
animals were randomly divided into 3 groups of 4 goats
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each. Each goat was treated with a single intramuscular
(IM) injection of medetomidine HCl (40 μg/kg) (Domitor,
Orion Corporation, Turku, Finland). In a preliminary
experiment this dosage was observed to induce sedation
and recumbency in goats. After the onset of recumbency,
each goat was placed on its right side and injected with 5
ml of physiological saline solution (control group), 0.2
mg/kg of atipamezole HCl (Orion Corp.), or 0.2 mg/kg of
yohimbine HCl (BDH Ltd., Poole, UK) via the jugular vein.
Yohimbine was freshly prepared as a 0.2% aqueous
solution. The doses of atipamezole and yohimbine were
selected from a previous sheep study (11).

within 10-20 min. The duration of recumbency in the
control group was 90 ± 9 min (mean ± SE). The control
goats remained sedated even after regaining the righting
reflex and standing. Atipamezole and yohimbine
significantly (P < 0.05) reduced the recumbency period to
2 ± 1 and 45 ± 8 min, respectively, in comparison with
the control group. The signs of arousal in the antagonist
groups consisted of head raising, moving into sternal
recumbency, and standing within 1 min (atipamezole
group) or 15-20 min (yohimbine group). In contrast to
the control group, the atipamezole- and yohimbinetreated goats appeared alert after standing.

The duration of recumbency was determined from the
time of antagonist injection to the moment the righting
reflex was regained. Heart rate and rumen motility
baseline values were determined before injection of
medetomidine, and before antagonist administration and
immediately after regaining the righting reflex. Heart rate
and rumen motility were monitored with a stethoscope.
The data were subjected to analysis of variance, followed
by the least significant difference test (14). The level of
significance was P < 0.05.

Medetomidine injection significantly decreased heart
rate and ruminal motility (Table). Atipamezole
significantly, but only partially, reversed medetomidineinduced reductions in heart rate and ruminal contractions,
whereas yohimbine partially reversed the decrease in
heart rate only (Table).

Results
Medetomidine injected intramuscularly at the dose
rate of 40 μg/kg induced sedation in goats, as evidenced
by drooping of the head, ataxia, and reluctance to move.
The goats became recumbent and lost the righting reflex

Discussion
Atipamezole effectively antagonized the depressant
effect (recumbency) of medetomidine in goats. Yohimbine
was less effective as an antagonist of medetomidine, as it
shortened the duration of recumbency by only 50% in
comparison to the control group. The antagonistic effects
of atipamezole and yohimbine on medetomidine-induced
sedation have been reported in sheep (11,12). A similar
antagonistic effect of atipamezole has also been reported

Table. Effects of atipamezole and yohimbine (0.2 mg/kg, intravenously) on medetomidine (40 μg/kg,
intramuscularly)-induced changes in the heart rate (HR, beats/min) and ruminal motility (RM, contractions/5
min) in goats.

Before medetomidine

After regaining
the righting reflex

Before antagonist

Antagonist
HR

RM

HR

RM

HR

RM

Saline (5 ml)

76 ± 29

4.0 ± 1.1

41 ± 10a

0±0

a

50 ± 12

1.3 ± 0.9

Atipamezole

68 ± 6

3.3 ± 0.3

36 ± 5a

0 + 0a

48 ± 4ab

1.6 ± 0.3ab

Yohimbine

61 ± 1

2.6 ± 0.3*

29 ± 1*a

0 ± 0a

39 ± 1a

0 ± 0*†a

ab

Values are presented as the mean ± SE of the 4 goat groups. Antagonists were injected after the animals became
recumbent (within 10-20 min of medetomidine administration).
*Significantly different than the control group, P < 0.05.
†Significantly different than the atipamezole value, P < 0.05.
a
Significantly different than the pre-medetomidine value, P < 0.05.
b
Significantly different than the pre-antagonist value, P < 0.05.
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in goats (7). The present study confirms the antagonistic
action of atipamezole on medetomidine-induced sedation,
whereas yohimbine only partially antagonized the effects
of medetomidine. A higher yohimbine dose was not tried
in the goats because the antagonistic dose of yohimbine
(0.2 mg/kg, intravenously) was reported to be highly
effective in reversing recumbency in sheep treated with
medetomidine (11) or xylazine, another alpha 2adrenoceptor agonist (15). Atipamezole is a more
selective alpha 2-adrenoceptor antagonist than yohimbine
(16,17). Both antagonists increase the central release and
turnover of norepinephrine (12,16,17), which in turn
causes arousal and alertness.
Bradycardia and ruminal atony, as side effects of
medetomidine, have been reported in goats (6,7,13) and
sheep (5,8,11,12); however, these side effects are
transient in nature (7,13) in sheep (5,8,11,12) and goats
(13). Therefore, after medetomidine antagonism and
arousal, sides effects are expected to regress even faster
(7,13). In the present study atipamezole partially
reversed bradycardia and ruminal atony, whereas
yohimbine partially reversed bradycardia only. It is not
known whether the timing (10-20 min after

medetomidine administration) of antagonist injection
could have influenced the ability of each one to reverse
the side effects of medetomidine; however, the reversal
of medetomidine sedation was consistent in the
atipamezole (2 ± 1 min) and yohimbine (45 ± 8 min)
groups. In accordance with the findings of the present
study, 0.2 and 0.4 mg/kg of yohimbine intravenously
administered was also partially effective in preventing
xylazine-induced bradycardia in sheep (18).
In conclusion, the data suggest that atipamezole is
useful for antagonizing the central nervous system
depressant effects of medetomidine in goats. Atipamezole
was also superior to yohimbine as a medetomidine
antagonist in goats.
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